Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.

Nigeria risks falling behind in the global knowledge and technology race unless it urgently strengthens university-led research through adequate funding and sustained partnerships with industry, ...

A hidden antibiotic, forged inside a familiar microbe and overlooked for years, has turned out to be roughly 100 times more ...

The 3rd Next-Generation Conjugates Summit (Boston | February 26-28, 2024) is the only event dedicated to showcasing conjugate drugs with novel payloads and formats, providing unrivalled access to 30+ ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can precisely ...